Investors Pump $33M in CoreValve

Investors Pump $33M in CoreValve: "CoreValve, a company that is developing a way for doctors to replace defective heart valves without opening up the chest, is paving the way for innovation in the cardiovascular market, leading investors to pump $33 million into the company in a third financing round."